News New medicines review process under NHS 10-Year Plan emerges More details have emerged of a UK plan for new medicines to get simultaneous decisions from the MHRA and NICE on their use by the NHS.
News UK biotech investment "holding firm", says BIA The UK life sciences raised £1.23bn in venture capital investment in the first half of 2025, although there was a fallback in the second quarter.
News UK plans to invest 'billions' in Essex biosecurity centre The UK government has revealed a plan to open a multibillion-pound biosecurity facility to protect the country from emerging public health threats.
News UK plan to lead life sciences gets mixed response The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.
News Bayer bags first world approval for hot flush therapy Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.
News UK authority cracks down on weight-loss drug ads Nine adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting prescription-only drugs.
News NHS to offer Wegovy to a million more people in England The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.